-
-
-
-
-
-
-
Rhelion Life Sciences Wholly Owned Subsidiary Filament Health Completes Shipment of PEX010 for University of Washington Phase 2a Trial in Cancer-Related Anxiety and Depression
-
-
-
-
-
-
-
Red Light Holland Announces Corporate Rebrand to Rhelion Life Sciences Corp
-
-
-
-
-
-
-
Red Light Holland subsidiary signs psilocybin supply deal with Paris hospital
-
-
-
-
-
-
-
Red Light Holland Highlights Publication of Randomized Clinical Trial Showing a Single Dose of Psilocybin Reduced Cocaine Use, with Filament Health Holding the Exclusive License to the Data and Intell
-
-
-
-
-
-
-
Red Light Holland Showcases Growing Clinical Demand for Filament Health's PEX010 with New and Repeat University Shipments
-
-
-
-
-
-
-
RETRANSMISSION: Red Light Holland Signs Definitive Agreement with Filament Health to Expand Its Platform for Natural Psychedelic Drug Development and Microdosing Innovation
-
-
-
-
-
-
-
Red Light Holland Secures Second United States Controlled Substances Import Permit for the Company's Psilocybin Through FDA-Compliant, DEA-Registered Partner Irvine Labs
-
461,256 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

